Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancerJoan Chang, Thomas R. Cox|Oncotarget|2017Cited by 107
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid MetabolismElysse C. Filipe, Thomas R. Cox|Advanced Science|2024Cited by 23
The importance of developing therapies targeting the biological spectrum of metastatic diseaseAndries Zijlstra, Julio A. Aguirre‐Ghiso, Dihua Yu et al.|Clinical & Experimental Metastasis|2019Cited by 13